Stentrode for Lou Gehrig's Disease

(FOCUS-CAN Trial)

This trial aims to test a device called the Stentrode, which might help people with Lou Gehrig's Disease (ALS) regain control over daily activities using a brain-computer interface. The study seeks individuals diagnosed with ALS or motor neuron disease who have significant weakness in both arms. Those who have had ALS for a while and face challenges using their arms may find this trial suitable. Participants need a supportive home environment and a caregiver to assist with study visits and device use. As an unphased trial, this study offers a unique opportunity to contribute to groundbreaking research that could improve the quality of life for ALS patients.

The trial information does not specify if you need to stop taking your current medications. However, if you are on treatments that might interfere with the device implant, such as certain imaging or therapies, you may need to discuss this with the study team.

Research has shown that the Stentrode device is generally safe for people with Lou Gehrig's disease (ALS). In a study with six ALS patients, researchers found the Stentrode to be safe, with no serious problems reported. Specifically, there were no major issues like severe injuries or life-threatening situations. Another study followed participants for a year and found the device did not cause disability or death. These findings suggest that patients tolerate the Stentrode well and it does not cause severe side effects.¹²³⁴⁵

Unlike traditional treatments for Lou Gehrig's Disease (ALS), which often include medications to manage symptoms and slow disease progression, the Stentrode offers a groundbreaking approach. The Stentrode is a tiny brain implant designed to help patients control external devices using their thoughts, potentially improving communication and mobility. Researchers are excited because this device taps into the brain's signals without invasive surgery, using blood vessels as a natural pathway. This novel delivery method could significantly enhance the quality of life for ALS patients, offering a new level of independence.

Research has shown that the Stentrode, a device connecting the brain to a computer, may assist people with Lou Gehrig's disease, also known as ALS. In previous studies, four patients with ALS used the Stentrode to complete online tasks solely through thought. This suggests the device might enable them to communicate and interact with the world again. Importantly, no serious side effects occurred, indicating it as a safe option. While these results are promising, the current trial will further investigate its effectiveness and safety in a larger group of patients.²⁵⁶⁷⁸